Reference
Windschall D, et al. Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis. Clinical Rheumatology 35: 2925-2931, No. 12, Dec 2016. Available from: URL: http://doi.org/10.1007/s10067-016-3439-y - Germany
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1641, 20 (2017). https://doi.org/10.1007/s40278-017-26934-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-26934-3